Explanatory note

These Regulations are made in exercise of the powers conferred by the European Union (Withdrawal) Act 2018 (c.16) in order to address failures of retained EU law to operate effectively and other deficiencies (in particular section 8(2)(a), (c), (d) and (g)) arising from the withdrawal of the United Kingdom from the European Union.

These Regulations amend retained direct EU legislation in the field of transmissible spongiform encephalopathies and animal by-products.

An impact assessment has not been produced for this instrument as no, or no significant, impact on the private or voluntary sector is foreseen.